Seres Therapeutics
MCRB
MCRB
79 hedge funds and large institutions have $227M invested in Seres Therapeutics in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 37 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.11% more ownership
Funds ownership: 4.6% → 4.71% (+0.11%)
12% less capital invested
Capital invested by funds: $258M → $227M (-$30.4M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $144K
Holders
79
Holding in Top 10
2
Calls
–
Puts
$144K
Top Buyers
| 1 | +$2.11M | |
| 2 | +$2.11M | |
| 3 | +$751K | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$686K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$608K |
Top Sellers
| 1 | -$2.24M | |
| 2 | -$612K | |
| 3 | -$395K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$374K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$316K |